FSD Pharma (HUGE) Stock Price, News & Analysis

Company Overview

FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.

Key Stats

• Today's Range: $0.23 to $0.23
• 50-Day Range: $0.08 to $0.20
• 52-Week Range: $0.07 to $1.68
• Volume: N/A
• Average Volume: 10.14 million shs
• Market Capitalization: $9.11 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HUGE Stock Analysis - Frequently Asked Questions

How were FSD Pharma's earnings last quarter?

FSD Pharma Inc. (NASDAQ:HUGE) posted its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.11.

What other stocks do shareholders of FSD Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that FSD Pharma investors own include Meta Platforms (META), SNDL (SNDL), AMC Entertainment (AMC), Ford Motor (F), NVIDIA (NVDA), Fiverr International (FVRR) and NIO (NIO).

Company Calendar

• Last Earnings: 11/14/2023
• Today: 6/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HUGE
• CIK: 1771885
• Web: fsdpharma.com
• Phone: (416) 854-8884
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.26)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$17.90 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -74.06%
• Return on Assets: -55.31%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.34
• Quick Ratio: 2.34

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.33 per share
• Price / Book: 0.69

Miscellaneous

• Outstanding Shares: 40,117,000
• Free Float: 36,695,000
• Market Cap: $9.11 million
• Optionable: Optionable
• Beta: 0.60